Javascript must be enabled to continue!
Antimicrobial Agents and Chemotherapy
View through Europeana Collections
Up-to-date information regarding the antibiotic susceptibility of Neisseria meningitidis strains from African countries is highly limited. Our aim was to comprehensively describe the antibiotic susceptibilities of a selection of N. meningitidis isolates recovered between 2000 and 2006 from 18 African countries, mainly those within the meningitis belt. Susceptibilities to 11 antibiotics were determined using Etest for 137 N. meningitidis isolates (stringently selected from 693 available isolates). The isolates were also characterized by serogrouping, multilocus sequence typing, genosubtyping, and penA allele identification. All N. meningitidis isolates were susceptible to ceftriaxone, chloramphenicol, and ciprofloxacin. No isolate produced beta-lactamase. Only three isolates (2%) displayed reduced susceptibility to penicillin G. The two isolates with the highest penicillin G MICs were the only isolates showing reduced susceptibility to ampicillin and cefuroxime. One of these isolates was also resistant to penicillin V. One percent of isolates displayed reduced susceptibility to rifampin, while 52% of the isolates were resistant to tetracycline, 74% were resistant to erythromycin, and 94% were resistant to sulfadiazine. The MICs of rifampin and tetracycline seemed to be associated with the serogroup of the isolates. In total, 18 sequence types (STs), 10 genosubtypes, and 8 different penA alleles were identified; the most common were ST-7, P1.20,9,35-1, and penA4, respectively. A high level of correlation was found between ST, genosubtype, and penA allele. In conclusion, N. meningitidis isolates from the African meningitis belt remain highly susceptible to the antibiotics used. Regarding beta-lactam antibiotics, rare isolates showed a reduced susceptibility to penicillins, but the expanded-spectrum cephalosporins are not affected at present.
Title: Antimicrobial Agents and Chemotherapy
Description:
Up-to-date information regarding the antibiotic susceptibility of Neisseria meningitidis strains from African countries is highly limited.
Our aim was to comprehensively describe the antibiotic susceptibilities of a selection of N.
meningitidis isolates recovered between 2000 and 2006 from 18 African countries, mainly those within the meningitis belt.
Susceptibilities to 11 antibiotics were determined using Etest for 137 N.
meningitidis isolates (stringently selected from 693 available isolates).
The isolates were also characterized by serogrouping, multilocus sequence typing, genosubtyping, and penA allele identification.
All N.
meningitidis isolates were susceptible to ceftriaxone, chloramphenicol, and ciprofloxacin.
No isolate produced beta-lactamase.
Only three isolates (2%) displayed reduced susceptibility to penicillin G.
The two isolates with the highest penicillin G MICs were the only isolates showing reduced susceptibility to ampicillin and cefuroxime.
One of these isolates was also resistant to penicillin V.
One percent of isolates displayed reduced susceptibility to rifampin, while 52% of the isolates were resistant to tetracycline, 74% were resistant to erythromycin, and 94% were resistant to sulfadiazine.
The MICs of rifampin and tetracycline seemed to be associated with the serogroup of the isolates.
In total, 18 sequence types (STs), 10 genosubtypes, and 8 different penA alleles were identified; the most common were ST-7, P1.
20,9,35-1, and penA4, respectively.
A high level of correlation was found between ST, genosubtype, and penA allele.
In conclusion, N.
meningitidis isolates from the African meningitis belt remain highly susceptible to the antibiotics used.
Regarding beta-lactam antibiotics, rare isolates showed a reduced susceptibility to penicillins, but the expanded-spectrum cephalosporins are not affected at present.
Related Results
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract
Introduction
Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer
The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer
Abstract
Background
Leukocytes play an important role in cancer development. However, the impact of chemotherapy-associated neutropenia/lymphopen...
Changes in oral microbiota after the initiation of chemotherapy in patients with hematopoietic tumors
Changes in oral microbiota after the initiation of chemotherapy in patients with hematopoietic tumors
Abstract
Background
Recently, the gut microbiota has been shown to play an important role in the response and resistance to chemotherapy. Although there is much knowledge ...
ANTIMICROBIAL RESISTANCE: REVIEW
ANTIMICROBIAL RESISTANCE: REVIEW
Antimicrobial resistance (AMR) is resistance of a microorganism to an antimicrobial that was originally effective for treatment of infections caused by it. Increasing clinical inci...
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract
Pancreatic adenocarcinoma (PDAC) remains one of the most lethal cancers today and is expected to be the second cause of cancer death in the coming decade. M...
Exploring perspectives on antimicrobial stewardship: a qualitative study of health managers in Kenya
Exploring perspectives on antimicrobial stewardship: a qualitative study of health managers in Kenya
Abstract
Background: Antimicrobial resistance is a significant public health concern with the establishment of antimicrobial stewardship in hospitals being obligatory now m...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Awareness Regarding Antimicrobial Use and Antimicrobial Resistance among Health Care Professionals and Lay Persons
Awareness Regarding Antimicrobial Use and Antimicrobial Resistance among Health Care Professionals and Lay Persons
BACKGROUND
Globally antimicrobial resistance is rising, and the Indian scenario is also similar to antimicrobial awareness. The study literature on awareness regarding antimi...

